Connect Biopharma Holdings Limited Investment Income, Nonoperating
Connect Biopharma Holdings Limited (CNTB) reported Investment Income, Nonoperating of $313.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2026-08-12
- Connect Biopharma Holdings Limited investment income, nonoperating for the quarter ending 2026-06-30 was $313.00K, a 49.43% decline year-over-year.
- Connect Biopharma Holdings Limited investment income, nonoperating for the quarter ending 2026-03-31 was $260.00K, a 63.89% decline year-over-year.
- Connect Biopharma Holdings Limited investment income, nonoperating for the quarter ending 2025-12-31 was $384.00K, a 54.77% decline year-over-year.
- Connect Biopharma Holdings Limited investment income, nonoperating for the quarter ending 2025-09-30 was $545.00K, a 51.98% decline year-over-year.
- Connect Biopharma Holdings Limited investment income, nonoperating for fiscal 2025 was $2.27M, a 49.07% decline from fiscal 2024.
- Connect Biopharma Holdings Limited investment income, nonoperating for fiscal 2024 was $4.45M, a 14.74% decline from fiscal 2023.
- Connect Biopharma Holdings Limited investment income, nonoperating for fiscal 2023 was $5.22M.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $313.00K 10-Q · filed 2026-08-12 | $573.00K 10-Q · filed 2026-08-12 | $957.00K derived: sum of 3 quarters · filed 2026-08-12 | $1.50M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $260.00K 10-Q · filed 2026-05-12 | $644.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.19M derived: sum of 3 quarters · filed 2026-05-12 | $1.81M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $929.00K derived: sum of 2 quarters · filed 2026-03-31 | $1.55M derived: sum of 3 quarters · filed 2026-08-12 | $2.27M 10-K · filed 2026-03-31 |
| 2025-09-30 | $545.00K 10-Q · filed 2025-11-12 | $1.16M derived: sum of 2 quarters · filed 2026-08-12 | $1.88M 10-Q · filed 2025-11-12 | $2.73M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $619.00K 10-Q · filed 2026-08-12 | $1.34M 10-Q · filed 2026-08-12 | $2.19M derived: sum of 3 quarters · filed 2026-08-12 | $3.32M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $720.00K 10-Q · filed 2026-05-12 | $1.57M derived: sum of 2 quarters · filed 2026-05-12 | $2.70M derived: sum of 3 quarters · filed 2026-05-12 | $3.93M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $849.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.98M derived: sum of 2 quarters · filed 2026-03-31 | $3.21M derived: sum of 3 quarters · filed 2026-03-31 | $4.45M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.14M 10-Q · filed 2025-11-12 | $2.36M derived: sum of 2 quarters · filed 2025-11-12 | $3.60M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.22M 10-Q · filed 2025-08-13 | $2.47M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $1.25M 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $5.22M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |